NCT07114601 A Study of LY4257496 in Participants With Cancer (OMNIRAY) Status RECRUITING Phase PHASE1
NCT07101328 A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) Status NOT_YET_RECRUITING Phase PHASE1
NCT07100119 A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis Status RECRUITING Phase PHASE1
NCT07073170 A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT07059130 Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis Status NOT_YET_RECRUITING Phase PHASE4
NCT07046559 A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants Status RECRUITING Phase PHASE1
NCT07044271 A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants Status COMPLETED Phase PHASE1
NCT07035093 A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain Status RECRUITING Phase PHASE3
NCT07030868 A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes Status TERMINATED Phase PHASE2
NCT07006792 A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06993792 A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE3